by emma
7. October 2011 15:13
Merck’s chairman of its board of directors, Richard T. Clark, has decided to take retirement in December.
The former president and CEO of Merck will be replaced by Kenneth C. Frazier as the board’s new chair.
Mr Frazier thanked the outgoing chairman for the “leadership and the innumerable contributions he has made to our company and our industry”.
He first joined Merck back in 1972 and went on to lead the company for five years between 2005 and 2010. Mr Clark has served as a director at the company since May 2005 and became chairman in 2007.
“I have been a part of Merck for more than 39 years – I always have and always will consider Merck to be an important part of my life and my extended family,” said Mr Clark. “It has been a great pleasure to work with the talented, dedicated people of Merck who are so committed to our mission of saving and improving lives around the world.
“I am confident that under Ken Frazier's leadership, the company is well positioned for continued success in the future.”
cc5fe7dc-b623-4eeb-a53b-68a0cbdc27c5|0|.0
Tags: Merck, chair, chairman, retire, retirement, Board of Directors, Richard Clark, President, CEO, former, Kenneth Frazier, replacement, replace, leadership, management, company, industry, pharma, pharmaceuticals, drugs, treatment, therapy, jobs, career, recruitment, medicine, medication, success, future, appoint, appointment
Appointments
Subscribe